OTC: LABFF - Laboratorios Farmaceuticos Rovi, S.A.

Yield per half year: 0%
Dividend yield: +3.96%
Sector: Healthcare

Share chart Laboratorios Farmaceuticos Rovi, S.A.

Extended chart Simple chart
Financial Markets by TradingView

About Laboratorios Farmaceuticos Rovi, S.A.

Laboratorios Farmaceuticos Rovi, S.A. engages in the research, development, production, and sale of pharmaceutical products in Spain, European Union, OECD countries, and internationally. The company distributes other products that are licensed from other laboratories. Its principal products include Ameride, Bertanel, Bluxam, Enoxaparin Rovi, Calcium Vitamine D3 Rovi, Exxiv, Prinvil, Rhodogil, Glufan, Hibor, Hirobriz Breezhaler, Neparvis, Medicebran, Medikinet, Mysimba, Orvatez, Tryptizol, Ulunar Breezhaler, and Volutsa.

more details
It provides non-prescription pharmaceutical products; and contract-manufacturing services to other companies for a range of pharmaceutical forms, including prefilled syringes, vials, suppositories, tablets, hard capsules, and sachets. The company was incorporated in 1946 and is headquartered in Madrid, Spain. Laboratorios Farmaceúticos Rovi, S.A. is a subsidiary of Norbel Inversiones, S.L.
Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Див.доход ао 3.96
Дивиденд ао 2.11
Сайт https://www.rovi.es
Цена ао 86.05
Change price per day: 0% (90.61)
Change price per week: 0% (90.61)
Change price per month: 0% (90.61)
Change price per 3 month: 0% (90.61)
Change price per half year: 0% (90.61)
Change price per year: +74.25% (52)
Change price per 3 year: +31.8% (68.75)
Change price per 5 year: 0% (90.61)
Change price per 10 year: 0% (90.61)
Change price per year to date: 0% (90.61)
All parameters

Underestimation

Title Value Grade
P/S 3.02 5
P/BV 5.09 3
P/E 14.7 8
EV/EBITDA 10.35 7
Total: 5.88

Efficiency

Title Value Grade
ROA, % 23.55 7
ROE, % 34.92 9
Total: 6.83

Dividends

Title Value Grade
Div yield, % 3.96 9.9
DSI 0.9 9
Total: 6.56

Debt

Title Value Grade
Debt/EBITDA 0.1905 10
Total: 10

Growth impulse

Title Value Grade
Yield Revenue, % 136.19 10
Yield Ebitda, % 337.35 10
Yield EPS, % 388.3 10
Total: 8
More

Institutions Volume Share, %
Price (T.Rowe) International Discovery Fund 830932 1.54
Vanguard International Stock Index-Total Intl Stock Indx 281370 0.52
Victory Portfolios-Victory Trivalent International Small Cap Fund 222468 0.41
Vanguard Tax Managed Fund-Vanguard Developed Markets Index Fund 169903 0.31
Price (T.Rowe) International Small-Cap Equity Trust 134631 0.25
iShares Core MSCI EAFE ETF 114899 0.21
DFA Continental Small Company Series 113531 0.21
DFA International Core Equity Portfolio 104540 0.19
iShares MSCI EAFE Small Cap ETF 91619 0.17
Vanguard Intl Equity Index Fds-FTSE All World ex U.S.Small Cap Index 83291 0.15



Head Job title Payment Year of birth
Mr. Juan Lopez-Belmonte Encina Chairman & CEO 1.25M
Mr. Ivan Lopez-Belmonte Encina Second Deputy Chairman & GM of Commercial and Development 505.46k
Mr. Javier Lopez-Belmonte Encina First Deputy Chairman, GM of Industrial Operations & CFO 507.61k
Marta Campos Martínez Head of Investor Relations N/A
Ms. Mercedes Benítez del Castillo Sánchez Legal Department Manager N/A
Ms. Rosario Perucha Pérez Marketing Manager N/A
Mr. Francisco Javier Angulo García Human Resources Manager N/A
Mr. Gabriel Nunez Fernandez Secretary N/A
Ms. Beatriz Ávila Alcalde Sales Manager N/A

Address: Spain, Madrid, Calle José Isbert. 2 - open in Google maps, open in Yandex maps
Website: https://www.rovi.es